About: David Crook

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: David Crook Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher (ORCID 0000-0002-9587-3730)

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) 연구원 (ko) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) araştırmacı (tr) эрдэмтэн (mn) वैज्ञानिक (hi) 研究者 (zh) հետազոտող (hy) hulumtues (sq) onderzoeker (nl) researcher (ORCID 0000-0002-9587-3730) (en)
exact match	wds:Q38642612-ADAA81DB-E14D-4C93-B63C-9BDB5CCC2AA8
exact match	https://scigraph.springernature.com/person.014542676022.40
rdfs:label	David Crook (en) David Crook (nl) David Crook (es) David Crook (it) David Crook (sl) David Crook (ast)
skos:prefLabel	David Crook (en) David Crook (nl) David Crook (es) David Crook (it) David Crook (sl) David Crook (ast)
name	David Crook (en) David Crook (nl) David Crook (es) David Crook (it) David Crook (sl) David Crook (ast)
given name	wds:Q38642612-FC9F4EBA-6C3F-404B-96F1-2E8DFF3065D5
given name	David
instance of	wds:Q38642612-BBDDEE8D-2E62-45C9-B4ED-298B55CB3B2A
instance of	Homo sapiens
occupation	wds:Q38642612-88D6D67D-5C59-4351-990D-19977F6B7548
employer	wds:Q38642612-9950D2C7-7E25-49B5-849A-381FF5B7BA4A
sex or gender	wds:Q38642612-7963E6BE-CD5F-45BC-B4F0-DF9F84FD57A9
educated at	wds:Q38642612-83EC4E71-E56B-4FDB-AB47-762DF0E8CF9F
occupation	researcher
employer	University of Brighton – Falmer Campus
sex or gender	male
educated at	University of Bristol
ORCID iD	wds:Q38642612-BB107C24-DEA3-423D-BB43-6737E542D64C
Dimensions author ID	wds:Q38642612-8315B096-3EBD-4949-85D0-D2BCB935CFEB
ORCID iD	https://orcid.org/0000-0002-9587-3730
ORCID iD	0000-0002-9587-3730
Dimensions author ID	014542676022.40
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q38642612
is author of	A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Using the UK primary care Quality and Outcomes Framework to audit health care equity: preliminary data on diabetes management Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins Do different brands of oral contraceptives differ in their effects on cardiovascular disease? A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins. Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism. Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Coronary heart disease risk markers in users of low-dose oral contraceptives. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up. A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis Elevated serum lipoprotein(a) levels in young women with endometriosis. Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. UK Desogen Study Group. Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age. Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk Lifestyle factors, hormonal contraception, and premenstrual symptoms: the United Kingdom Southampton Women's Survey Influence of age and menopause on serum lipids and lipoproteins in healthy women. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions Plasma lipoprotein lipids in relation to the MspI polymorphism of the apolipoprotein AII gene in Caucasian men. Lack of association with plasma triglyceride concentration Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses Clinical and metabolic considerations of long-term oral contraceptive use Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men Post-menopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. A Literature Review of the Pharmacokinetics and Pharmacodynamics of Dobutamine in Neonates Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism. Transdermal administration of oestrogen/progestagen hormone replacement therapy Tibolone lowers high density lipoprotein cholesterol by increasing hepatic lipase activity but does not impair cholesterol efflux Umbilical vessel wall fatty acids after normal and retarded fetal growth. Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women. Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software